Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signalling to p53: where does it all start?

M B Kastan1

  • 1Johns Hopkins University, Baltimore, MD 21205, USA.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.

Pediatric blood & cancer·2013
Same author

Cellular survival pathways and resistance to cancer therapy.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2006
Same author

The ATM-dependent DNA damage signaling pathway.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

HSV-1 amplicon vector-mediated expression of ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.

Gene therapy·2003
Same author

Multiple signaling pathways involving ATM.

Cold Spring Harbor symposia on quantitative biology·2003
Same author

ATM--a key determinant of multiple cellular responses to irradiation.

Acta oncologica (Stockholm, Sweden)·2002

The p53 tumor suppressor protein can be activated by depleted ribonucleotide pools, not just DNA damage. This finding offers new insights into p53 signaling pathways and potential therapeutic strategies for cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Alterations in the p53 gene are critical in human cancer development.
  • The p53 protein's growth-suppressive functions are initiated by specific cellular signals.
  • DNA damage is a known inducer of p53 activity.

Purpose of the Study:

  • To investigate novel signals that can induce p53 activation.
  • To explore the role of ribonucleotide pools in p53 signaling.
  • To understand alternative pathways for p53 induction beyond DNA damage.

Main Methods:

  • The study involved analyzing cellular responses to conditions of depleted ribonucleotide pools.
  • Experiments were conducted to assess p53 induction in the absence of detectable DNA damage.

Related Experiment Videos

  • The research focused on characterizing the signaling cascade initiated by ribonucleotide depletion.

    • Main Results:

    • Depletion of cellular ribonucleotide pools was found to induce the p53 protein.
    • This induction occurred even when significant DNA damage was not detectable.
    • These findings suggest a novel mechanism for p53 activation.

    Conclusions:

    • Ribonucleotide pool status represents a new upstream regulator of p53.
    • This discovery expands our understanding of cellular stress responses and p53 signaling.
    • It opens new avenues for therapeutic interventions targeting p53 in cancer treatment.